Patient persistence with first-line antiglaucomatous monotherapy

PURPOSE: To identify the extent of persistence (period of time of continuous therapy with the drug prescribed) of glaucoma patients treated with prostaglandins (latanoprost, bimatoprost, or travoprost), or β-blocker (timolol) monotherapy. METHODS: An observational retrospective study of a 24-month f...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias, Alfonso, Schargel, Konrad, Ussa, Fernando, Canut, Maria I, Robles, Amelia y Belén, Sánchez, Belén Martí
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861932/
https://www.ncbi.nlm.nih.gov/pubmed/20463793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861932/
https://www.ncbi.nlm.nih.gov/pubmed/20463793

Ejemplares similares